Table 1.
Clinical data for patients with HBV and/or HCV infection
| Group BC | Group B | Group C | Statistical value | |
| Number of patients | 40 | 16 | 31 | |
| Sex (male/female) | 21/19 | 6/10 | 15/16 | χ2 = 1.030, P > 0.05 |
| Age (y)a | 39 ± 5 (29-50) | 40 ± 6 (31-53) | 39 ± 3 (32-44) | F = 0.48, P > 0.05 |
| Time of infection (y)a | 16 ± 5 (14-21) | 16 ± 5 (14-21) | 17 ± 4 (14-21) | F = 2.27, P > 0.05 |
| Serological markers (1994) | ||||
| HBsAg + | 34 (85.0%) | 16 (100%) | 0 | |
| HBeAg + | 11 (27.5%) | 7 (43.8%) | 0 | |
| HBVDNA + | 37 (92.5%) | 14 (87.5%) | 0 | |
| HCVRNA + | 11 (27.5%) | 0 (0%) | 19 (61.3%) | |
| Anti-HCV | 39 (97.5%) | 0 (0%) | 31 (100.0%) |
a
Data were expressed as mean ± SD (range).